<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38992084</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2730-664X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>11</Day></PubDate></JournalIssue><Title>Communications medicine</Title><ISOAbbreviation>Commun Med (Lond)</ISOAbbreviation></Journal><ArticleTitle>Insights from an N3C RECOVER EHR-based cohort study characterizing SARS-CoV-2 reinfections and Long COVID.</ArticleTitle><Pagination><StartPage>129</StartPage><MedlinePgn>129</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">129</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43856-024-00539-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although the COVID-19 pandemic has persisted for over 3 years, reinfections with SARS-CoV-2 are not well understood. We aim to characterize reinfection, understand development of Long COVID after reinfection, and compare severity of reinfection with initial infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We use an electronic health record study cohort of over 3 million patients from the National COVID Cohort Collaborative as part of the NIH Researching COVID to Enhance Recovery Initiative. We calculate summary statistics, effect sizes, and Kaplan-Meier curves to better understand COVID-19 reinfections.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Here we validate previous findings of reinfection incidence (6.9%), the occurrence of most reinfections during the Omicron epoch, and evidence of multiple reinfections. We present findings that the proportion of Long COVID diagnoses is higher following initial infection than reinfection for infections in the same epoch. We report lower albumin levels leading up to reinfection and a statistically significant association of severity between initial infection and reinfection (chi-squared value: 25,697, p-value: &lt;0.0001) with a medium effect size (Cramer's V: 0.20, DoF&#x2009;=&#x2009;3). Individuals who experienced severe initial and first reinfection were older in age and at a higher mortality risk than those who had mild initial infection and reinfection.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In a large patient cohort, we find that the severity of reinfection appears to be associated with the severity of initial infection and that Long COVID diagnoses appear to occur more often following initial infection than reinfection in the same epoch. Future research may build on these findings to better understand COVID-19 reinfections.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hadley</LastName><ForeName>Emily</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0074-4344</Identifier><AffiliationInfo><Affiliation>RTI International, Durham, NC, USA. ehadley@rti.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Yun Jae</ForeName><Initials>YJ</Initials><Identifier Source="ORCID">0000-0003-2144-8480</Identifier><AffiliationInfo><Affiliation>Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Saaya</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4674-2646</Identifier><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laraway</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0450-7074</Identifier><AffiliationInfo><Affiliation>University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preiss</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7966-527X</Identifier><AffiliationInfo><Affiliation>RTI International, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Rob</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6979-1766</Identifier><AffiliationInfo><Affiliation>RTI International, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-1245-2034</Identifier><AffiliationInfo><Affiliation>Patient Led Research Collaborative (PLRC), Calabasas, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brannock</LastName><ForeName>M Daniel</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0001-8095-547X</Identifier><AffiliationInfo><Affiliation>RTI International, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chute</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0001-5437-2545</Identifier><AffiliationInfo><Affiliation>Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfaff</LastName><ForeName>Emily R</ForeName><Initials>ER</Initials><Identifier Source="ORCID">0000-0002-6840-9756</Identifier><AffiliationInfo><Affiliation>University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loomba</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haendel</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9114-8737</Identifier><AffiliationInfo><Affiliation>University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Elaine</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2494-317X</Identifier><AffiliationInfo><Affiliation>University of Rochester Medical Center, Rochester, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>N3C and RECOVER consortia</CollectiveName></Author><Author ValidYN="Y"><LastName>Moffitt</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2723-5902</Identifier><AffiliationInfo><Affiliation>Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OTA OT2HL161847</GrantID><Agency>U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Med (Lond)</MedlineTA><NlmUniqueID>9918250414506676</NlmUniqueID><ISSNLinking>2730-664X</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>More than three years after the start of the COVID-19 pandemic, individuals are frequently reporting multiple COVID-19 infections. However, these reinfections remain poorly understood. Here, we investigate COVID-19 reinfections in a large electronic health record cohort of over 3 million patients. We use data summary techniques and statistical tests to characterize reinfections and their relationships with disease severity, biomarkers, and Long COVID. We find that individuals with severe initial infection are more likely to experience severe reinfection, that some protein levels are lower, leading to reinfection, and that a lower proportion of individuals are diagnosed with Long COVID following reinfection than initial infection. Our work highlights the prevalence and impact of reinfections and suggests the need for further research.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></OtherAbstract><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>11</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38992084</ArticleId><ArticleId IdType="pmc">PMC11239932</ArticleId><ArticleId IdType="doi">10.1038/s43856-024-00539-2</ArticleId><ArticleId IdType="pii">10.1038/s43856-024-00539-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/.</Citation></Reference><Reference><Citation>Pinto LM, Nanda V, Sunavala A, Rodriques C. Reinfection in COVID-19: a scoping review. Armed Forces Med. J. India. 2021;77:S257&#x2013;S263. doi: 10.1016/j.mjafi.2021.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mjafi.2021.02.010</ArticleId><ArticleId IdType="pmc">PMC8313064</ArticleId><ArticleId IdType="pubmed">34334891</ArticleId></ArticleIdList></Reference><Reference><Citation>Falahi S, Kenarkoohi A. COVID-19 reinfection: prolonged shedding or true reinfection? New Microbes New Infect. 2020;38:100812. doi: 10.1016/j.nmni.2020.100812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2020.100812</ArticleId><ArticleId IdType="pmc">PMC7657875</ArticleId><ArticleId IdType="pubmed">33200033</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Kaperak C, Sato T, Sakuraba A. COVID-19 reinfection: a rapid systematic review of case reports and case series. J. Investig. Med. 2021;69:1253&#x2013;1255. doi: 10.1136/jim-2021-001853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-001853</ArticleId><ArticleId IdType="pubmed">34006572</ArticleId></ArticleIdList></Reference><Reference><Citation>Medi&#x107;, S. et al. Risk and severity of SARS-CoV-2 reinfections during 2020&#x2013;2022 in Vojvodina, Serbia: a population-level observational study. Lancet Reg. Health&#x2014;Eur.20, 100453 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9246704</ArticleId><ArticleId IdType="pubmed">35791336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawandi A, et al. Suspected severe acute respiratory syndrome Coronavirus 2 (SARS-COV-2) reinfections: incidence, predictors, and healthcare use among patients at 238 US healthcare facilities, 1 June 2020 to 28 February 2021. Clin. Infect. Dis. 2022;74:1489&#x2013;1492. doi: 10.1093/cid/ciab671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab671</ArticleId><ArticleId IdType="pmc">PMC8436398</ArticleId><ArticleId IdType="pubmed">34351392</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a Rodr&#xed;guez M, et al. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with wild-type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico. Front. Public Health. 2023;11:1149795. doi: 10.3389/fpubh.2023.1149795.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1149795</ArticleId><ArticleId IdType="pmc">PMC10174068</ArticleId><ArticleId IdType="pubmed">37181688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukwishaka J, Ndayishimiye Y, Destine E, Danwang C, Kirakoya-Samadoulougou F. Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis. BMC Public Health. 2023;23:778. doi: 10.1186/s12889-023-15626-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-15626-7</ArticleId><ArticleId IdType="pmc">PMC10140730</ArticleId><ArticleId IdType="pubmed">37118717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X, et al. Reinfection in patients with COVID-19: a systematic review. Glob. Health Res. Policy. 2022;7:12. doi: 10.1186/s41256-022-00245-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41256-022-00245-3</ArticleId><ArticleId IdType="pmc">PMC9051013</ArticleId><ArticleId IdType="pubmed">35488305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma KC, et al. Trends in laboratory-confirmed SARS-CoV-2 reinfections and associated hospitalizations and deaths among adults aged &#x2265;18 years&#x2014;18 U.S. Jurisdictions, September 2021&#x2013;December 2022. Morb. Mortal. Wkly. Rep. 2023;72:683&#x2013;689. doi: 10.15585/mmwr.mm7225a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7225a3</ArticleId><ArticleId IdType="pmc">PMC10328471</ArticleId><ArticleId IdType="pubmed">37347715</ArticleId></ArticleIdList></Reference><Reference><Citation>Toro-Huamanchumo CJ, et al. Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review. New Microbes New Infect. 2022;48:101021. doi: 10.1016/j.nmni.2022.101021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2022.101021</ArticleId><ArticleId IdType="pmc">PMC9420201</ArticleId><ArticleId IdType="pubmed">36060548</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman, S., Rahman, M. M., Miah, M. &amp; Begum, M. N. COVID-19 reinfections among naturally infected and vaccinated individuals. Sci. Rep. 12, 1438 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8792012</ArticleId><ArticleId IdType="pubmed">35082344</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulliam JRC, et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science. 2022;376:eabn4947. doi: 10.1126/science.abn4947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn4947</ArticleId><ArticleId IdType="pmc">PMC8995029</ArticleId><ArticleId IdType="pubmed">35289632</ArticleId></ArticleIdList></Reference><Reference><Citation>Swift MD, Hainy CM, Sampathkumar P, Breeher LE. Multiple SARS-CoV-2 reinfections: a case series of thrice-infected individuals. Mayo Clin. Proc. 2022;97:1021&#x2013;1023. doi: 10.1016/j.mayocp.2022.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2022.03.003</ArticleId><ArticleId IdType="pmc">PMC8913293</ArticleId><ArticleId IdType="pubmed">35512873</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, C.-H., Lin, S.-W., Shen, C.-F., Hsieh, K.-S. &amp; Cheng, C.-M. Biomarkers during COVID-19: mechanisms of change and implications for patient outcomes. Diagnostics (Basel)12, 509 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8870804</ArticleId><ArticleId IdType="pubmed">35204599</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E, et al. Hematological findings and complications of COVID-19. Am. J. Hematol. 2020;95:834&#x2013;847. doi: 10.1002/ajh.25829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25829</ArticleId><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Bivona G, Agnello L, Ciaccio M. Biomarkers for prognosis and treatment response in COVID-19 patients. Ann. Lab. Med. 2021;41:540&#x2013;548. doi: 10.3343/alm.2021.41.6.540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3343/alm.2021.41.6.540</ArticleId><ArticleId IdType="pmc">PMC8203437</ArticleId><ArticleId IdType="pubmed">34108281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y-J, et al. Biomarkers in long COVID-19: a systematic review. Front. Med. 2023;10:1085988. doi: 10.3389/fmed.2023.1085988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaheen NA, et al. COVID-19 reinfection: a multicenter retrospective study in Saudi Arabia. Ann. Thorac. Med. 2022;17:81&#x2013;86. doi: 10.4103/atm.atm_74_22.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/atm.atm_74_22</ArticleId><ArticleId IdType="pmc">PMC9150659</ArticleId><ArticleId IdType="pubmed">35651891</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan MM, Reddy AJ, Rothberg MB. Reinfection rates among patients who previously tested positive for Coronavirus Disease 2019: a Retrospective Cohort Study. Clin. Infect. Dis. 2021;73:1882&#x2013;1886. doi: 10.1093/cid/ciab234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab234</ArticleId><ArticleId IdType="pmc">PMC7989568</ArticleId><ArticleId IdType="pubmed">33718968</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinov, G. K., Mladenov, M., Rangachev, A. &amp; Alexiev, I. SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria. PLoS ONE17, e0274509 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9462809</ArticleId><ArticleId IdType="pubmed">36084070</ArticleId></ArticleIdList></Reference><Reference><Citation>Desimmie, B. A. et al. Insights into SARS-CoV-2 persistence and its relevance. Viruses13, 1025 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8228265</ArticleId><ArticleId IdType="pubmed">34072390</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Long COVID or Post-COVID Conditions (Centers for Disease Control and Prevention, 2022).</Citation></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 2022;28:2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly, Z., Bowe, B. &amp; Xie, Y. Outcomes of SARS-CoV-2 Reinfection (Research Square, 2022).</Citation></Reference><Reference><Citation>National Center for Advancing Translational Sciences. National COVID Cohort Collaborative (N3C). https://ncats.nih.gov/n3c (National Center for Advancing Translational Sciences, 2020).</Citation></Reference><Reference><Citation>Bradwell, K. R., Wooldridge, J. T. &amp; Amor, B. Harmonizing units and values of quantitative data elements in a very large nationally pooled electronic health record (EHR) dataset. J. Am. Med. Inform. Assoc.29, 1172&#x2013;1182 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9196692</ArticleId><ArticleId IdType="pubmed">35435957</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain ME, et al. Prolonged viral shedding in patients with mild to moderate COVID-19 disease: a regional perspective. Infect. Dis. 2021;14:11786337211010428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8047841</ArticleId><ArticleId IdType="pubmed">33911876</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao H-R, et al. Factors associated with delayed viral shedding in COVID-19 infected patients: a retrospective small-scale study. Respir. Med. 2021;178:106328. doi: 10.1016/j.rmed.2021.106328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106328</ArticleId><ArticleId IdType="pmc">PMC7866845</ArticleId><ArticleId IdType="pubmed">33588209</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo IL, et al. Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau. Int. J. Biol. Sci. 2020;16:1698&#x2013;1707. doi: 10.7150/ijbs.45357.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.45357</ArticleId><ArticleId IdType="pmc">PMC7098032</ArticleId><ArticleId IdType="pubmed">32226287</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 2020;26:672&#x2013;675. doi: 10.1038/s41591-020-0869-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0869-5</ArticleId><ArticleId IdType="pubmed">32296168</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. CDC Museum COVID-19 Timeline (Centers for Disease Control and Prevention, 2022).</Citation></Reference><Reference><Citation>Pfaff, E. R. et al. Coding long COVID: characterizing a new disease through an ICD-10 lens. BMC Med21, 58 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931566</ArticleId><ArticleId IdType="pubmed">36793086</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987;40:373&#x2013;383. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am. J. Epidemiol. 2011;173:676&#x2013;682. doi: 10.1093/aje/kwq433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq433</ArticleId><ArticleId IdType="pubmed">21330339</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyke KE, et al. Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant. Cell Rep. Med. 2022;3:100679. doi: 10.1016/j.xcrm.2022.100679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100679</ArticleId><ArticleId IdType="pmc">PMC9212999</ArticleId><ArticleId IdType="pubmed">35798000</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y. &amp; Rockl&#xf6;v, J. The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta. J. Travel Med. 29, taac037 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8992231</ArticleId><ArticleId IdType="pubmed">35262737</ArticleId></ArticleIdList></Reference><Reference><Citation>Willett BJ, et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat. Microbiol. 2022;7:1161&#x2013;1179. doi: 10.1038/s41564-022-01143-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-022-01143-7</ArticleId><ArticleId IdType="pmc">PMC9352574</ArticleId><ArticleId IdType="pubmed">35798890</ArticleId></ArticleIdList></Reference><Reference><Citation>Eythorsson E, Runolfsdottir HL, Ingvarsson RF, Sigurdsson MI, Palsson R. Rate of SARS-CoV-2 reinfection during an Omicron wave in Iceland. JAMA Netw Open. 2022;5:e2225320. doi: 10.1001/jamanetworkopen.2022.25320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.25320</ArticleId><ArticleId IdType="pmc">PMC9350711</ArticleId><ArticleId IdType="pubmed">35921113</ArticleId></ArticleIdList></Reference><Reference><Citation>Washington State Department of Health. Reported reinfections with SARS-CoV-2 in Washington State, February 2022. https://doh.wa.gov/sites/default/files/2022-02/421-024-ReportedReinfections.pdf (2022).</Citation></Reference><Reference><Citation>Bielecki M, et al. Social distancing alters the clinical course of COVID-19 in young adults: a comparative cohort study. Clin. Infect. Dis. 2021;72:598&#x2013;603. doi: 10.1093/cid/ciaa889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa889</ArticleId><ArticleId IdType="pmc">PMC7337655</ArticleId><ArticleId IdType="pubmed">32594121</ArticleId></ArticleIdList></Reference><Reference><Citation>US Coronavirus vaccine tracker. USAFacts. https://usafacts.org/visualizations/covid-vaccine-tracker-states (2022).</Citation></Reference><Reference><Citation>Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging. 2020;12:9959&#x2013;9981. doi: 10.18632/aging.103344.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103344</ArticleId><ArticleId IdType="pmc">PMC7288963</ArticleId><ArticleId IdType="pubmed">32470948</ArticleId></ArticleIdList></Reference><Reference><Citation>Letizia AG, et al. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study. Lancet Respir. Med. 2021;9:712&#x2013;720. doi: 10.1016/S2213-2600(21)00158-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00158-2</ArticleId><ArticleId IdType="pmc">PMC8049591</ArticleId><ArticleId IdType="pubmed">33865504</ArticleId></ArticleIdList></Reference><Reference><Citation>Slezak J, et al. Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients. Clin. Microbiol. Infect. 2021;27:1860.e7&#x2013;1860.e10. doi: 10.1016/j.cmi.2021.07.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.07.030</ArticleId><ArticleId IdType="pmc">PMC8373524</ArticleId><ArticleId IdType="pubmed">34419576</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechmann N, et al. Sexual dimorphism in COVID-19: potential clinical and public health implications. Lancet Diabetes Endocrinol. 2022;10:221&#x2013;230. doi: 10.1016/S2213-8587(21)00346-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00346-6</ArticleId><ArticleId IdType="pmc">PMC8803381</ArticleId><ArticleId IdType="pubmed">35114136</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelrahman MM, Abd-Elrahman NM, Bakheet TM. Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study. J. Med. Virol. 2021;93:5942&#x2013;5946. doi: 10.1002/jmv.27156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27156</ArticleId><ArticleId IdType="pmc">PMC8426945</ArticleId><ArticleId IdType="pubmed">34171139</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen, N. N., Nguyen, Y. N., Hoang, V. T., Million, M. &amp; Gautret, P. SARS-CoV-2 reinfection and severity of the disease: a systematic review and meta-analysis. Viruses15, (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10145185</ArticleId><ArticleId IdType="pubmed">37112949</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AE, et al. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam. Pract. 2016;17:38. doi: 10.1186/s12875-016-0440-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12875-016-0440-0</ArticleId><ArticleId IdType="pmc">PMC4815064</ArticleId><ArticleId IdType="pubmed">27036116</ArticleId></ArticleIdList></Reference><Reference><Citation>Brett, K. M. &amp; Burt, C. W. Utilization of ambulatory medical care by women: United States, 1997&#x2013;98. Vital Health Stat. 13149, 1&#x2013;46 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11478128</ArticleId></ArticleIdList></Reference><Reference><Citation>Koupaei M, et al. Clinical manifestations, treatment options, and comorbidities in COVID-19 relapse patients: a systematic review. J. Clin. Lab. Anal. 2022;36:e24402. doi: 10.1002/jcla.24402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.24402</ArticleId><ArticleId IdType="pmc">PMC9102618</ArticleId><ArticleId IdType="pubmed">35396748</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis N, et al. Effectiveness associated with vaccination after COVID-19 recovery in preventing reinfection. JAMA Netw. Open. 2022;5:e2223917. doi: 10.1001/jamanetworkopen.2022.23917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.23917</ArticleId><ArticleId IdType="pmc">PMC9331088</ArticleId><ArticleId IdType="pubmed">35895058</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, et al. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study. Clin. Chem. Lab. Med. 2020;58:1106&#x2013;1115. doi: 10.1515/cclm-2020-0377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0377</ArticleId><ArticleId IdType="pubmed">32352397</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther. Adv. Respir. Dis. 2020;14:1753466620937175. doi: 10.1177/1753466620937175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753466620937175</ArticleId><ArticleId IdType="pmc">PMC7336828</ArticleId><ArticleId IdType="pubmed">32615866</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, et al. Hypoalbuminemia&#x2014;an indicator of the severity and prognosis of COVID-19 patients: a Multicentre Retrospective Analysis. Infect. Drug Resist. 2021;14:3699&#x2013;3710. doi: 10.2147/IDR.S327090.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S327090</ArticleId><ArticleId IdType="pmc">PMC8437137</ArticleId><ArticleId IdType="pubmed">34526790</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali KM, Ali AM, Tawfeeq HM, Figueredo GP, Rostam HM. Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019. J. Med. Virol. 2021;93:4532&#x2013;4536. doi: 10.1002/jmv.27002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27002</ArticleId><ArticleId IdType="pmc">PMC8250600</ArticleId><ArticleId IdType="pubmed">33830538</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz M, Fatima R, Lee-Smith W, Assaly R. The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis. Crit. Care. 2020;24:255. doi: 10.1186/s13054-020-02995-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02995-3</ArticleId><ArticleId IdType="pmc">PMC7249975</ArticleId><ArticleId IdType="pubmed">32456658</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, et al. Serum albumin levels are a predictor of COVID-19 patient prognosis: evidence from a single cohort in Chongqing, China. Int. J. Gen. Med. 2021;14:2785&#x2013;2797. doi: 10.2147/IJGM.S312521.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S312521</ArticleId><ArticleId IdType="pmc">PMC8238547</ArticleId><ArticleId IdType="pubmed">34194238</ArticleId></ArticleIdList></Reference><Reference><Citation>Uscher-Pines L, Pines J, Kellermann A, Gillen E, Mehrotra A. Emergency department visits for nonurgent conditions: systematic literature review. Am. J. Manag. Care. 2013;19:47&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4156292</ArticleId><ArticleId IdType="pubmed">23379744</ArticleId></ArticleIdList></Reference><Reference><Citation>Bots SH, Groenwold RHH, Dekkers OM. Using electronic health record data for clinical research: a quick guide. Eur. J. Endocrinol. 2022;186:E1&#x2013;E6. doi: 10.1530/EJE-21-1088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-21-1088</ArticleId><ArticleId IdType="pubmed">35157608</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadley, E. et al. Code for Publication: Insights from an N3C RECOVER EHR-based Cohort Study Characterizing SARS-CoV-2 Reinfections and Long COVID. 10.5281/zenodo.10699193 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11239932</ArticleId><ArticleId IdType="pubmed">38992084</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>